We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial) (TiPPIH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01434849
Recruitment Status : Terminated (Difficulty with enrolled patients to complete trial.)
First Posted : September 15, 2011
Last Update Posted : November 15, 2016
Information provided by (Responsible Party):
Alice K. Gong, The University of Texas Health Science Center at San Antonio

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 2016
  Study Completion Date : April 2016